These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 29341321)
1. Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α. Wang K; Zhu X; Zhang K; Yin Y; Chen Y; Zhang T J Biochem Mol Toxicol; 2018 Mar; 32(3):e22039. PubMed ID: 29341321 [TBL] [Abstract][Full Text] [Related]
2. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849 [TBL] [Abstract][Full Text] [Related]
3. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts. Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195 [TBL] [Abstract][Full Text] [Related]
4. Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro. Tanaka T; Ikegami Y; Nakazawa H; Kuriyama N; Oki M; Hanai J; Sukhatme VP; Kaneki M J Cell Physiol; 2017 Jan; 232(1):192-201. PubMed ID: 27137755 [TBL] [Abstract][Full Text] [Related]
5. HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells. Nishimoto A; Kugimiya N; Hosoyama T; Enoki T; Li TS; Hamano K Int J Oncol; 2014 Jun; 44(6):2077-84. PubMed ID: 24718784 [TBL] [Abstract][Full Text] [Related]
6. STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line. Soleymani Abyaneh H; Gupta N; Radziwon-Balicka A; Jurasz P; Seubert J; Lai R; Lavasanifar A Cancers (Basel); 2017 Oct; 9(10):. PubMed ID: 29036915 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL. Hernandez-Luna MA; Rocha-Zavaleta L; Vega MI; Huerta-Yepez S Leuk Lymphoma; 2013 May; 54(5):1048-55. PubMed ID: 23013270 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways. Wang S; Yao Y; Yao M; Fu P; Wang W Biochem Biophys Res Commun; 2018 Sep; 503(3):1605-1609. PubMed ID: 30072097 [TBL] [Abstract][Full Text] [Related]
9. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer. Regan Anderson TM; Ma SH; Raj GV; Cidlowski JA; Helle TM; Knutson TP; Krutilina RI; Seagroves TN; Lange CA Cancer Res; 2016 Mar; 76(6):1653-63. PubMed ID: 26825173 [TBL] [Abstract][Full Text] [Related]
10. Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2. Koh SY; Moon JY; Unno T; Cho SK Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875792 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway. Li H; Sun X; Li J; Liu W; Pan G; Mao A; Liu J; Zhang Q; Rao L; Xie X; Sheng X Neoplasia; 2022 Oct; 32():100821. PubMed ID: 35985176 [TBL] [Abstract][Full Text] [Related]
12. Induction of hypoxia-inducible factor-1α by BDNF protects retinoblastoma cells against chemotherapy-induced apoptosis. Gao Y; Jing M; Ge R; Lang L Mol Cell Biochem; 2016 Mar; 414(1-2):77-84. PubMed ID: 26868822 [TBL] [Abstract][Full Text] [Related]
13. Picrasidine G decreases viability of MDA-MB 468 EGFR-overexpressing triple-negative breast cancer cells through inhibition of EGFR/STAT3 signaling pathway. Yamashita N; Kondo M; Zhao S; Li W; Koike K; Nemoto K; Kanno Y Bioorg Med Chem Lett; 2017 Jun; 27(11):2608-2612. PubMed ID: 28427809 [TBL] [Abstract][Full Text] [Related]
14. Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy. Liu Q; Guan C; Liu C; Li H; Wu J; Sun C Biomed Pharmacother; 2022 Dec; 156():113861. PubMed ID: 36228375 [TBL] [Abstract][Full Text] [Related]
15. Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy. Tan Q; Wang H; Hu Y; Hu M; Li X; Aodengqimuge ; Ma Y; Wei C; Song L Cancer Sci; 2015 Aug; 106(8):1023-32. PubMed ID: 26041409 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841 [TBL] [Abstract][Full Text] [Related]
17. Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells. Mir Hassani Z; Nabiuni M; Parivar K; Abdirad S; Karimzadeh L Med Oncol; 2021 Jun; 38(7):77. PubMed ID: 34076777 [TBL] [Abstract][Full Text] [Related]
18. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872 [TBL] [Abstract][Full Text] [Related]
19. A perylene derivative regulates HIF-1α and Stat3 signaling pathways. Chen H; Guan Y; Yuan G; Zhang Q; Jing N Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121 [TBL] [Abstract][Full Text] [Related]
20. The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling. von Wahlde MK; Hülsewig C; Ruckert C; Götte M; Kiesel L; Bernemann C Gynecol Endocrinol; 2015 Feb; 31(2):160-4. PubMed ID: 25356777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]